Roche Receives CE Mark for Multiple Sclerosis Blood Test
Roche has received the CE mark for its Elecsys Neurofilament Light Chain (NfL) for the detection of neuroinflammation…
Association of reduced DTI-ALPS index and increased free water with glymphatic system alterations in noise-induced hearing loss: a neuroimaging study
Subjects According to the national standard of the People’s Republic of China, GBZ 49-2014 “Diagnosis of Occupational Noise…
Roche Receives CE Mark for Blood-Based Immunoassay Test to Detect Alzheimer’s Genetic Risk Factor ApoE4
Roche has received CE Mark approval for its Elecsys Apolipoprotein E4 (ApoE4) biomarker test, an in-vitro diagnostic (IVD)…
Reliability and validity of the Roche PD Mobile Application for remote monitoring of early Parkinson’s disease
Reliability and validity of the Roche PD Mobile Application v2 The Roche PD Mobile Application v1 was designed…
Roche Shares Alzheimer’s Drug and Diagnostic Advances at AAIC 2025
Roche is presenting new data from its Alzheimer’s development portfolio at the Alzheimer’s Association International Conference, taking place…